AFT Pharmaceuticals Limited
NZSE AFT.NZ
AFT Pharmaceuticals Limited Gross Profit for the year ending March 31, 2024: USD 52.77 M
AFT Pharmaceuticals Limited Gross Profit is USD 52.77 M for the year ending March 31, 2024, a 16.95% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.
-
AFT Pharmaceuticals Limited Gross Profit for the year ending March 31, 2023 was USD 45.12 M, a 6.20% change year over year.
-
AFT Pharmaceuticals Limited Gross Profit for the year ending March 31, 2022 was USD 42.49 M, a 25.44% change year over year.
-
AFT Pharmaceuticals Limited Gross Profit for the year ending March 31, 2021 was USD 33.87 M, a 18.60% change year over year.
-
AFT Pharmaceuticals Limited Gross Profit for the year ending March 31, 2020 was USD 28.56 M, a 3.68% change year over year.
Key data
| Date | Gross Profit | Operating Income | EBIT | EBITDA |
|---|
Market news
Loading...
NZSE: AFT.NZ
| CEO | Dr. Hartley Atkinson Ph.D. |
| IPO Date | Dec. 21, 2015 |
| Location | New Zealand |
| Headquarters | 129 Hurstmere Road |
| Employees | 110 |
| Sector | Health Care |
| Industries | |
Description
AFT Pharmaceuticals Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally. It offers products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, nail care, oral care, pain management, skin care, and supplements, as well as other products. AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email